Optimization of immunomagnetic selection of myeloma cells from bone marrow using magnetic activated cell sorting
- PMID: 20694533
- DOI: 10.1007/s12185-010-0651-4
Optimization of immunomagnetic selection of myeloma cells from bone marrow using magnetic activated cell sorting
Abstract
Plasma cells (PCs) enrichment from bone marrow samples of multiple myeloma (MM) patients is frequently performed by immunomagnetic separation (magnetic activated cell sorting, MACS) using anti-CD138 MicroBeads. The aim of our work was to find optimal strategy for immunomagnetic separation of PCs and determine optimal algorithm of separation techniques for samples with various percentage of neoplastic cells. From 2007 to 2008, selection of PCs using separation programs Possels and Posseld(2) was carried out on 234 bone marrow samples obtained from 208 MM patients. In 2008, an optimal algorithm for separation programs was introduced based on the analysis of the previous experiments. The Possels program is applicable for samples with >10% PCs in the mononuclear fraction, while the Posseld(2) program is used for samples with 5-10% PCs in the mononuclear fraction. Median purity of 92.6% for the positive fraction of cells (range 14.5-99.6%) and median recovery of 60.4% (range 25.7-99.5%) were obtained when the Possels program was applied (n = 45). A total of 80% (36/45) of processed samples had purity of >70%. Median purity for the positive fraction of 83.7% (range 14.3-99.7%) and median recovery of 14.3% (range 3.6-50.0%) were achieved using the Posseld(2) program (n = 99). A total of 68% (67/99) of processed samples reached >70% purity. This separation strategy enabled us to obtain sufficient amounts of highly purified PCs required for subsequent research purposes. The MACS method has been unsuccessful if the percentage of PCs in the initial sample was <5%. These samples were processed by fluorescence activated cell sorting (FACS).
Similar articles
-
Application of an immune-magnetic cell sorting method for CD138-positive plasma cells in FISH analysis of multiple myeloma.Int J Lab Hematol. 2012 Oct;34(5):541-6. doi: 10.1111/j.1751-553X.2012.01433.x. Epub 2012 Jun 1. Int J Lab Hematol. 2012. PMID: 22672327
-
[Plasma cell separation algorithm from bone marrow samples].Klin Onkol. 2011;24(1):35-40. Klin Onkol. 2011. PMID: 21542274 Czech.
-
The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems.Bone Marrow Transplant. 1997 Jun;19(12):1239-46. doi: 10.1038/sj.bmt.1700812. Bone Marrow Transplant. 1997. PMID: 9208119
-
Comparison of purity and enrichment of CD34+ cells from bone marrow, umbilical cord and peripheral blood (primed for apheresis) using five separation systems.Stem Cells. 1995 Sep;13(5):524-32. doi: 10.1002/stem.5530130510. Stem Cells. 1995. PMID: 8528102
-
Sample processing and methodological pitfalls in multiple myeloma research.Klin Onkol. 2011;24 Suppl:S18-23. Klin Onkol. 2011. PMID: 21923059 Review.
Cited by
-
Growth factor independence 1 expression in myeloma cells enhances their growth, survival, and osteoclastogenesis.J Hematol Oncol. 2018 Oct 4;11(1):123. doi: 10.1186/s13045-018-0666-5. J Hematol Oncol. 2018. PMID: 30286780 Free PMC article.
-
Combined Selection System to Lower the Cutoff for Plasma Cell Enrichment Applied to iFISH Analysis in Multiple Myeloma.Transl Oncol. 2018 Jun;11(3):647-652. doi: 10.1016/j.tranon.2018.02.021. Epub 2018 Mar 30. Transl Oncol. 2018. PMID: 29604510 Free PMC article.
-
Dielectrophoresis for Biomedical Sciences Applications: A Review.Sensors (Basel). 2017 Feb 24;17(3):449. doi: 10.3390/s17030449. Sensors (Basel). 2017. PMID: 28245552 Free PMC article. Review.
-
Biobanking strategy and sample preprocessing for integrative research in monoclonal gammopathies.J Clin Pathol. 2017 Oct;70(10):847-853. doi: 10.1136/jclinpath-2017-204329. Epub 2017 Mar 30. J Clin Pathol. 2017. PMID: 28360189 Free PMC article.
-
Evaluation of plasma cell sorting methods in multiple myeloma patients: flow cytometry versus magnetic beads.Cancer Cell Int. 2025 Jan 17;25(1):16. doi: 10.1186/s12935-025-03647-8. Cancer Cell Int. 2025. PMID: 39825397 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous